136 related articles for article (PubMed ID: 2271512)
1. Urinary plasminogen activator activity in progressive renal failure.
Hong SY; Yang DH
Korean J Intern Med; 1990 Jan; 5(1):58-62. PubMed ID: 2271512
[TBL] [Abstract][Full Text] [Related]
2. [The study of plasminogen activator in renal cell carcinoma with special remarks on urokinase type plasminogen activator].
Hata M
Nihon Hinyokika Gakkai Zasshi; 1989 Nov; 80(11):1558-65. PubMed ID: 2512407
[TBL] [Abstract][Full Text] [Related]
3. Urinary epidermal growth factor excretion is correlated to renal function loss per se and not to the degree of diabetic renal failure.
ter Meulen CG; Bilo HJ; van Kamp GJ; Gans RO; Donker AJ
Neth J Med; 1994 Jan; 44(1):12-7. PubMed ID: 8202200
[TBL] [Abstract][Full Text] [Related]
4. Glomerular and tubular factors in urine flow rates of acute renal failure patients.
Rahman SN; Conger JD
Am J Kidney Dis; 1994 Jun; 23(6):788-93. PubMed ID: 8203359
[TBL] [Abstract][Full Text] [Related]
5. Phases of fluid and electrolyte homeostasis in the extremely low birth weight infant.
Lorenz JM; Kleinman LI; Ahmed G; Markarian K
Pediatrics; 1995 Sep; 96(3 Pt 1):484-9. PubMed ID: 7651782
[TBL] [Abstract][Full Text] [Related]
6. Interpretation of the Fractional Excretion of Sodium in the Absence of Acute Kidney Injury: A Cross-Sectional Study.
Schreuder MF; Bökenkamp A; van Wijk JAE
Nephron; 2017; 136(3):221-225. PubMed ID: 28391266
[TBL] [Abstract][Full Text] [Related]
7. Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes.
Ruggenenti P; Gaspari F; Perna A; Remuzzi G
BMJ; 1998 Feb; 316(7130):504-9. PubMed ID: 9501711
[TBL] [Abstract][Full Text] [Related]
8. Modulation of mRNA levels for urinary- and tissue-type plasminogen activator and plasminogen activator inhibitors 1 and 2 in human fibroblasts by interleukin 1.
Michel JB; Quertermous T
J Immunol; 1989 Aug; 143(3):890-5. PubMed ID: 2501387
[TBL] [Abstract][Full Text] [Related]
9. Urinary kallikrein excretion in chronic renal failure: relationship to blood pressure and the acute effect of captopril.
Cumming AD; Lambie AT
Ren Fail; 1987-1988; 10(3-4):161-7. PubMed ID: 3332725
[TBL] [Abstract][Full Text] [Related]
10. [Intraglomerular coagulation and fibrinolysis in human primary glomerular diseases].
Shibata K; Dohi K; Fujii Y; Ishikawa H
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):719-29. PubMed ID: 1770632
[TBL] [Abstract][Full Text] [Related]
11. Construction and expression of hybrid plasminogen activators prepared from tissue-type plasminogen activator and urokinase-type plasminogen activator genes.
Lee SG; Kalyan N; Wilhelm J; Hum WT; Rappaport R; Cheng SM; Dheer S; Urbano C; Hartzell RW; Ronchetti-Blume M
J Biol Chem; 1988 Feb; 263(6):2917-24. PubMed ID: 3125172
[TBL] [Abstract][Full Text] [Related]
12. Regulation of plasminogen activation in isolated perfused rat kidney.
Muellbacher W; Maier M; Binder BR
Am J Physiol; 1989 May; 256(5 Pt 2):F787-93. PubMed ID: 2719116
[TBL] [Abstract][Full Text] [Related]
13. Biological effects of combined inactivation of plasminogen activator and plasminogen activator inhibitor-1 gene function in mice.
Lijnen HR; Moons L; Beelen V; Carmelie P; Collen D
Thromb Haemost; 1995 Oct; 74(4):1126-31. PubMed ID: 8560424
[TBL] [Abstract][Full Text] [Related]
14. Vascular origin determines plasminogen activator expression in human endothelial cells. Renal endothelial cells produce large amounts of single chain urokinase type plasminogen activator.
Wojta J; Hoover RL; Daniel TO
J Biol Chem; 1989 Feb; 264(5):2846-52. PubMed ID: 2492525
[TBL] [Abstract][Full Text] [Related]
15. Functional adaptation of nephrons in dogs with acute progressing to chronic experimental glomerulonephritis.
Wagnild JP; Gutmann FD
J Clin Invest; 1976 Jun; 57(6):1575-89. PubMed ID: 932195
[TBL] [Abstract][Full Text] [Related]
16. Quantitative urinary protein excretion in chronic renal failure.
McMorrow RG; Galla JH; Luke RG
Am J Nephrol; 1982; 2(4):208-12. PubMed ID: 7148893
[TBL] [Abstract][Full Text] [Related]
17. Short-term effects of low protein-normal sodium diet on renal function in chronic renal failure.
Cianciaruso B; Bellizzi V; Capuano A; Bovi G; Nastasi A; Conte G; De Nicola L
Kidney Int; 1994 Mar; 45(3):852-60. PubMed ID: 8196288
[TBL] [Abstract][Full Text] [Related]
18. Residual plasminogen activator inhibitor activity after venous stasis as a criterion for hypofibrinolysis: a study in 83 patients with confirmed deep vein thrombosis.
Nguyen G; Horellou MH; Kruithof EK; Conard J; Samama MM
Blood; 1988 Aug; 72(2):601-5. PubMed ID: 3135860
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of six radionuclidic and non-radionuclidic methods for the assessment of glomerular filtration rate in patients with chronic renal failure].
Fotopoulos A; Bokharhli JA; Tsiouris S; Katsaraki A; Papadopoulos A; Tsironi M; Theodorou J
Hell J Nucl Med; 2006; 9(2):133-40. PubMed ID: 16894423
[TBL] [Abstract][Full Text] [Related]
20. Effect of metoclopramide on dopamine-induced changes in renal function in healthy controls and in patients with renal disease.
Smit AJ; Meijer S; Wesseling H; Donker AJ; Reitsma WD
Clin Sci (Lond); 1988 Oct; 75(4):421-8. PubMed ID: 2904313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
